🇺🇸 FDA
Pipeline program

Randomised, bioequivalence clinical trial of rasagiline 1 mg capsules vs rasagiline 1 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design.

UECHUP-RAS/24-2

Phase 1 other active

Quick answer

Randomised, bioequivalence clinical trial of rasagiline 1 mg capsules vs rasagiline 1 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design. for Parkinson´s disease is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratorios Tillomed Spain S.L.U
Indication
Parkinson´s disease
Phase
Phase 1
Modality
other
Status
active

Clinical trials